bluuebunny/crossref_metadata_2025_split huggingface dataset:
Intensity of pyrethroid resistance in Anopheles gambiae before and after a mass distribution of insecticide-treated nets in Kinshasa and in 11 provinces of the Democratic Republic of Congo
Authors: Wat’senga Francis , Agossa Fiacre , Manzambi Emile Z. , Illombe Gillon , Mapangulu Tania , Muyembe Tamfum , Clark Tiffany , Niang Mame , Ntoya Ferdinand , Sadou Aboubacar , Plucinski Mateusz , Li Yikun , Messenger Louisa A. , Fornadel Christen , Oxborough Richard M. , Irish Seth R. 
Published: April 2020

Abstract
Background
Between 2011 and 2018, an estimated 134.8 million pyrethroid-treated long-lasting insecticidal nets (LLINs) were distributed nationwide in the Democratic Republic of Congo (DRC) for malaria control. Pyrethroid resistance has developed in DRC in recent years, but the intensity of resistance and impact on LLIN efficacy was not known. Therefore, the intensity of resistance of Anopheles gambiae sensu lato (s.l.) to permethrin and deltamethrin was monitored before and after a mass distribution of LLINs in Kinshasa in December 2016, and in 6 other sites across the country in 2017 and 11 sites in 2018.

Methods
In Kinshasa, CDC bottle bioassays using 1, 2, 5, and 10 times the diagnostic dose of permethrin and deltamethrin were conducted using An. gambiae s.l. collected as larvae and reared to adults. Bioassays were conducted in four sites in Kinshasa province 6 months before a mass distribution of deltamethrin-treated LLINs and then two, six, and 10 months after the distribution. One site in neighbouring Kongo Central province was used as a control (no mass campaign of LLIN distribution during the study). Nationwide intensity assays were conducted in six sites in 2017 using CDC bottle bioassays and in 11 sites in 2018 using WHO intensity assays. A sub-sample of An. gambiae s.l. was tested by PCR to determine species composition and frequency of kdr-1014F and 1014S alleles.

Results
In June 2016, before LLIN distribution, permethrin resistance intensity was high in Kinshasa; the mean mortality rate was 43% at the 5× concentration and 73% at the 10× concentration. Bioassays at 3 time points after LLIN distribution showed considerable variation by site and time and there was no consistent evidence for an increase in pyrethroid resistance intensity compared to the neighbouring control site. Tests of An. gambiae s.l. in 6 sites across the country in 2017 and 11 sites in 2018 showed all populations were resistant to the diagnostic doses of 3 pyrethroids. In 2018, the intensity of resistance varied by site, but was generally moderate for all three pyrethroids, with survivors at ×5 the diagnostic dose. Anopheles gambiae sensu stricto (s.s.) was the most common species identified across 11 sites in DRC, but in Kinshasa, An. gambiae s.s. (91%) and Anopheles coluzzii (8%) were sympatric.

Conclusions
Moderate or high intensity pyrethroid resistance was detected nationwide in DRC and is a serious threat to sustained malaria control with pyrethroid LLINs. Next generation nets (PBO nets or bi-treated nets) should be considered for mass distribution.
Pharmacological prevention of surgery-accelerated metastasis in an animal model of osteosarcoma
Authors: Kallis Michelle P. , Maloney Caroline , Blank Brandon , Soffer Samuel Z. , Symons Marc , Steinberg Bettie M. 
Published: April 2020

Abstract
Background
Osteosarcoma is a highly metastatic primary bone tumor that predominantly affects adolescents and young adults. A mainstay of treatment in osteosarcoma is removal of the primary tumor. However, surgical excision itself has been implicated in promoting tumor growth and metastasis, an effect known as surgery-accelerated metastasis. The underlying mechanisms contributing to surgery-accelerated metastasis remain poorly understood, but pro-tumorigenic alterations in macrophage function have been implicated.

Methods
The K7M2-BALB/c syngeneic murine model of osteosarcoma was used to study the effect of surgery on metastasis, macrophage phenotype, and overall survival. Pharmacological prevention of surgery-accelerated metastasis was examined utilizing gefitinib, a receptor interacting protein kinase 2 inhibitor previously shown to promote anti-tumor macrophage phenotype.

Results
Surgical excision of the primary tumor resulted in increases in lung metastatic surface nodules, overall metastatic burden and number of micrometastatic foci. This post-surgical metastatic enhancement was associated with a shift in macrophage phenotype within the lung to a more pro-tumor state. Treatment with gefitinib prevented tumor-supportive alterations in macrophage phenotype and resulted in reduced metastasis. Removal of the primary tumor coupled with gefitinib treatment resulted in enhanced median and overall survival.

Conclusions
Surgery-accelerated metastasis is mediated in part through tumor supportive alterations in macrophage phenotype. Targeted pharmacologic therapies that prevent pro-tumor changes in macrophage phenotype could be utilized perioperatively to mitigate surgery-accelerated metastasis and improve the therapeutic benefits of surgery.
Harnessing the PRECISE network as a platform to strengthen global capacity for maternal and child health research in sub-Saharan Africa
Authors:   The PRECISE Network, Flint-O’Kane Meriel , von Dadelszen Peter , Makanga Prestige Tatenda , Sevene Esperança , Roca Anna , Dukes Peter , Hinrichs-Krapels Saba , Craik Rachel , Magee Laura A. , Temmerman Marleen 
Published: April 2020

AbstractIt is widely acknowledged across the global health sector that research programmes need to be designed and implemented in a way that maximise opportunities for strengthening local capacity. This paper examines how the United Kingdom Research and Innovation (UKRI) Grand Challenges Research Fund (GCRF) funded PRECISE (PREgnancy Care Integrating translational Science, Everywhere) Network has been established as a platform to strengthen global capacity for research focused on the improvement of maternal, fetal and newborn health in sub-Saharan Africa.Best practice principles outlined in an ESSENCE on Health Research report have been considered in relation to the PRECISE Network capacity-building activities described in this paper. These activities are described at the individual, programmatic and institutional levels, and successes, challenges and recommendations for future work are outlined.The paper concludes that the PRECISE leadership have an opportunity to review and refresh activity plans for capacity building at this stage in the project to build on achievements to date.
Cord blood DNA methylation reflects cord blood C-reactive protein levels but not maternal levels: a longitudinal study and meta-analysis
Authors: Yeung Edwina H. , Guan Weihua , Zeng Xuehuo , Salas Lucas A. , Mumford Sunni L. , de Prado Bert Paula , van Meel Evelien R. , Malmberg Anni , Sunyer Jordi , Duijts Liesbeth , Felix Janine F. , Czamara Darina , Hämäläinen Esa , Binder Elisabeth B. , Räikkönen Katri , Lahti Jari , London Stephanie J. , Silver Robert M. , Schisterman Enrique F. 
Published: April 2020

Abstract
Background
Prenatal inflammation has been proposed as an important mediating factor in several adverse pregnancy outcomes. C-reactive protein (CRP) is an inflammatory cytokine easily measured in blood. It has clinical value due to its reliability as a biomarker for systemic inflammation and can indicate cellular injury and disease severity. Elevated levels of CRP in adulthood are associated with alterations in DNA methylation. However, no studies have prospectively investigated the relationship between maternal CRP levels and newborn DNA methylation measured by microarray in cord blood with reasonable epigenome-wide coverage. Importantly, the timing of inflammation exposure during pregnancy may also result in different effects. Thus, our objective was to evaluate this prospective association of CRP levels measured during multiple periods of pregnancy and in cord blood at delivery which was available in one cohort (i.e., Effects of Aspirin in Gestation and Reproduction trial), and also to conduct a meta-analysis with available data at one point in pregnancy from three other cohorts from the Pregnancy And Childhood Epigenetics consortium (PACE). Secondarily, the impact of maternal randomization to low dose aspirin prior to pregnancy on methylation was assessed.

Results
Maternal CRP levels were not associated with newborn DNA methylation regardless of gestational age of measurement (i.e., CRP at approximately 8, 20, and 36 weeks among 358 newborns in EAGeR). There also was no association in the meta-analyses (all p > 0.5) with a larger sample size (n = 1603) from all participating PACE cohorts with available CRP data from first trimester (< 18 weeks gestation). Randomization to aspirin was not associated with DNA methylation. On the other hand, newborn CRP levels were significantly associated with DNA methylation in the EAGeR trial, with 33 CpGs identified (FDR corrected p < 0.05) when both CRP and methylation were measured at the same time point in cord blood. The top 7 CpGs most strongly associated with CRP resided in inflammation and vascular-related genes.

Conclusions
Maternal CRP levels measured during each trimester were not associated with cord blood DNA methylation. Rather, DNA methylation was associated with CRP levels measured in cord blood, particularly in gene regions predominately associated with angiogenic and inflammatory pathways.

Trial registration
Clinicaltrials.gov, NCT00467363, Registered April 30, 2007, http://www.clinicaltrials.gov/ct2/show/NCT00467363
The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer’s disease
Authors: Tondo Giacomo , Iaccarino Leonardo , Caminiti Silvia Paola , Presotto Luca , Santangelo Roberto , Iannaccone Sandro , Magnani Giuseppe , Perani Daniela 
Published: April 2020

Abstract
Background
Early-onset Alzheimer’s disease (EOAD) is characterized by young age of onset (< 65 years), severe neurodegeneration, and rapid disease progression, thus differing significantly from typical late-onset Alzheimer’s disease. Growing evidence suggests a primary role of neuroinflammation in AD pathogenesis. However, the role of microglia activation in EOAD remains a poorly explored field. Investigating microglial activation and its influence on the development of synaptic dysfunction and neuronal loss in EOAD may contribute to the understanding of its pathophysiology and to subject selection in clinical trials. In our study, we aimed to assess the amount of neuroinflammation and neurodegeneration and their relationship in EOAD patients, through positron emission tomography (PET) measures of microglia activation and brain metabolic changes.

Methods
We prospectively enrolled 12 EOAD patients, classified according to standard criteria, who underwent standard neurological and neuropsychological evaluation, CSF analysis, brain MRI, and both [18F]-FDG PET and [11C]-(R)-PK11195 PET. Healthy controls databases were used for statistical comparison. [18F]-FDG PET brain metabolism in single subjects and as a group was assessed by an optimized SPM voxel-wise single-subject method. [11C]-PK11195 PET binding potentials were obtained using reference regions selected with an optimized clustering procedure followed by a parametric analysis. We performed a topographic interaction analysis and correlation analysis in AD-signature metabolic dysfunctional regions and regions of microglia activation. A network connectivity analysis was performed using the interaction regions of hypometabolism and [11C]-PK11195 PET BP increases.

Results
EOAD patients showed a significant and extended microglia activation, as [11C]-PK11195 PET binding potential increases, and hypometabolism in typical AD-signature brain regions, i.e., temporo-parietal cortex, with additional variable frontal and occipital hypometabolism in the EOAD variants. There was a spatial concordance in the interaction areas and significant correlations between the two biological changes. The network analysis showed a disruption of frontal connectivity induced by the metabolic/microglia effects.

Conclusion
The severe microglia activation characterizing EOAD and contributing to neurodegeneration may be a marker of rapid disease progression. The coupling between brain glucose hypometabolism and local immune response in AD-signature regions supports their biological interaction.
Isolation of two iron-reducing facultative anaerobic electricigens and probing the application performance in eutrophication water
Authors: Zhang Xia , Zhang Hongpei , Wang Chuan , Chen Qianru , Zhao Yuqing , Zhou Qiaohong , Wu Zhenbin 
Published: April 2020

Abstract
Purpose
Sediment microbial fuel cell (SMFC) is a promising bioremediation technology in which microbes play an important role. Electricigens as the bio-catalysts have effect on pollution control and electricity generation. It is of great significance to screen the microorganisms with the ability of generating electricity.

Methods
The SMFC anode biofilm was used as microbiological source to study the feasibility of electricigens with iron-reducing property for eutrophication water treatment. Preliminarily, we isolated 20 facultative anaerobic pure bacteria and evaluated their cyclic voltammogram (CV) through the three-electrode system and electrochemical workstation. The power generation performance of strains was verified by air-cathode microbial fuel cells (AC-MFCs) under different single carbon sources.

Result
According to its morphological, physiological, and biochemical characteristics, along with phylogenetic analysis, the two strains (SMFC-7 and SMFC-17) with electrical characteristics were identified as Bacillus cereus. Compared with SMFC-7, SMFC-17 exhibited efficient NH4+-N and NO3−-N removal and PO43−-P accumulation from eutrophic solution with a removal rate of 79.91 ± 6.34% and 81.26 ± 1.11% and accumulation rate of 57.68 ± 4.36%, respectively.

Conclusion
The isolated bacteria SMFC-17 showed a good performance in eutrophic solution, and it might be a useful biocatalyst to enable the industrialized application of SMFC in eutrophic water treatment.
Safety and efficiency of gasless laparoscopy: a systematic review protocol
Authors: Shoman Haitham , Sandler Simone , Peters Alexander , Farooq Ameer , Gruendl Magdalen , Trinh Shauna , Little James , Woods Alex , Bolton William , Abioye Abubakar , Ljungman David 
Published: April 2020

AbstractBackgroundGasless laparoscopy, developed in the early 1990s, was a means to minimize the clinical and financial challenges of pneumoperitoneum and general anaesthesia. It has been used in a variety of procedures such as in general surgery and gynecology procedures including diagnostic laparoscopy. There has been increasing evidence of the utility of gasless laparoscopy in resource limited settings where diagnostic imaging is not available. In addition, it may help save costs for hospitals. The aim of this study is to conduct a systematic review of the available evidence surrounding the safety and efficiency of gasless laparoscopy compared to conventional laparoscopy and open techniques and to analyze the benefits that gasless laparoscopy has for low resource setting hospitals.MethodsThis protocol is developed by following the Preferred Reporting Items for Systematic review and Meta-Analysis–Protocols (PRISMA-P). The PRISMA statement guidelines and flowchart will be used to conduct the study itself. MEDLINE (Ovid), Embase, Web of Science, Cochrane Central, and Global Index Medicus (WHO) will be searched and the National Institutes of Health Clinical Trials database. The articles that will be found will be pooled into Covidence article manager software where all the records will be screened for eligibility and duplicates removed. A data extraction spreadsheet will be developed based on variables of interest set a priori. Reviewers will then screen all included studies based on the eligibility criteria. The GRADE tool will be used to assess the quality of the studies and the risk of bias in all the studies will be assessed using the Cochrane Risk assessment tool. The RoB II tool will assed the risk of bias in randomized control studies and the ROBINS I will be used for the non-randomized studies.DiscussionThis study will be a comprehensive review on all published articles found using this search strategy on the safety and efficiency of the use of gasless laparoscopy. The systematic review outcomes will include safety and efficiency of gasless laparoscopy compared to the use of conventional laparoscopy or laparotomy.Trial registrationThe study has been registered in PROSPERO under registration number:CRD42017078338
The great nursing brain drain and its effects on patient safety
Authors: Peters Alexandra , Palomo Rafael , Pittet Didier 
Published: April 2020

AbstractThe World Health Organization (WHO) has declared 2020 the “Year of the Nurse and Midwife”. On May 5th of this year, for the annual celebration of the SAVE LIVES: Clean Your Hands campaign, the WHO will focus on the critical role of nurses and midwives in promoting public health. The brain drain of healthcare workers (HCWs) leads to unequal distribution of nurses and midwives around the world, which affects the quality of care provided to patients. This phenomenon should be addressed as a global problem as it highlights staff shortages in the health system.
Testing satellite telemetry within narrow ecosystems: nocturnal movements and habitat use of bottlenose dolphins within a convoluted estuarine system
Authors: Hartel Elizabeth F. , Noke Durden Wendy , O’Corry-Crowe Greg 
Published: April 2020

Abstract
Background
While cetaceans have been extensively studied around the world, nocturnal movements and habitat use have been largely unaddressed for most populations. We used satellite telemetry to examine the nocturnal movements and habitat use of four bottlenose dolphins (Tursiops truncatus) from a well-studied population in a complex estuary along the east coast of Florida. This also enabled us to explore the utility of satellite tracking on an apex predator within a very narrow and convoluted ecosystem. Our objectives were to evaluate (1) nocturnal home ranges and how individual dolphins moved within them, (2) nocturnal utilization of habitats surrounding ocean inlets, (3) nocturnal movements outside of the population’s known range (i.e., the study area), and (4) nocturnal use of select environmental variables.

Results
Satellite tags were active between 129 and 140 days (136 ± 4.99) during nocturnal hours (summer/fall 2012), yielding 3.3 ± 1.4 high-quality transmissions per night. Results indicated substantial individual variation among the four tagged dolphins, with home ranges varying in length from 53.9 to 83.6 km (x̅ = 71.9 ± 12.9). Binomial tests and MaxEnt models revealed some dolphins preferred habitats surrounding inlets, seagrass habitats, and various water depths, while other dolphins avoided these areas. All dolphins, however, showed substantial movement (x̅ = 5.8 ± 7.4 km) outside of the study area, including travel into rivers/canals and the adjoining ocean (6.0–8.6% and 0.8–2.9% of locations per dolphin, respectively).

Conclusions
This study was the first to utilize satellite telemetry on Indian River Lagoon dolphins and provided the first detailed insights into the nocturnal movements and habitat use of this population. Our findings suggest that while individual dolphin home ranges may overlap, they use different foraging strategies, feed on different prey, and/or exhibit intraspecific resource partitioning. In contrast with a prior study, all tagged dolphins showed considerable movement into the adjoining ocean and freshwater sources. This suggests this population has a much larger range than previously thought, which is important to consider for future research and conservation efforts.
A simplified checklist for the visual inspection of finished pharmaceutical products: a way to empower frontline health workers in the fight against poor-quality medicines
Authors: Schiavetti B. , Wynendaele E. , Melotte V. , Van der Elst J. , De Spiegeleer B. , Ravinetto R. 
Published: April 2020

Abstract
Background
Substandard and falsified medicines, mainly prevalent in low and middle-income countries (LMICs), cause avoidable morbidity and mortality, and put at stake the performance of health systems. They may be prevented by an adequate implementation of pharmaceutical Quality Assurance (QA) guidelines, but unfortunately, most guidelines address upstream stakeholders and specialized staff in the supply chain. A multi-layered approach is needed, in order to empower the health workers at the point-of-care to proactively contribute to the fight against poor-quality medicines.
Visual inspection is a simple technique, suitable for field screening. The findings of a survey conducted in the Democratic Republic of the Congo (DRC) suggested that it might be a fairly good (yet partial) predictor of poor-quality, when compared to full laboratory tests.

Methods and results
Starting from the 68-questions checklist originally used in the survey in the DRC, we developed a simplified checklist, specifically designed to guide health workers at the point of care to rapidly identify suspect poor-quality medicines. We selected those medicines’ attributes the assessment of which does not require technical expertise, or access to regulatory information. Attributes were categorized according to a 3-level risk scale, to guide decision-making on suspect poor-quality medicines, based on an informed risk assessment.
The simplified checklist contains 26 binary questions (YES/NO), grouped into four themes: packaging, identification, traceability, and physical appearance. Each non-conformity corresponds to a level of risk for patients. The user is guided towards three possible actions: A) reasonably safe for dispensing; B) dispense with explanation; C) quarantine and make a risk-benefit evaluation before dispensing.

Conclusion
The simplified checklist should now be implemented in real-life setting in LMICs. If proven useful in guiding health workers at the point-of-care to take rapid, transparent, patient-centred actions when facing a suspect poor-quality medicine, it could be further extended to address specific formulations. Digitalization for linkage with pharmacovigilance programs could also be considered.